These results, suggesting an inverse correlation between GSC tumorigenicity and the general levels of m6A RNA methylation, were further corroborated by in vivo data, showing that the knock-down of METTL3 or METTL14, or both, significantly enhanced the growth of GSC-generated tumours. Here, METTL3 is linked to neoplasm.